Strativest CapitalSTRATIVEST RESEARCH
Independent research · Est. October 2026
← All X-Rays
Stock X-Ray · Consumer Staples · S&P 500 Full Coverage — Phase 1

Bunge Global (BG)

X-Ray dated Oct 28, 2026 · Share price as of Oct 28, 2026 intraday, when the valuation snapshot was captured · Financials from SEC filings (EDGAR) · Valuation multiples from a labelled secondary source
The verdict — valuation label: UNDERVALUED

Forward P/E is 9.67x against a peer median of 13.57x, a ratio of 0.71x — well below the 0.90 fair-range floor — with trailing P/E 19.72x and PEG not reported (shown as n/a on the statistics page). Latest-quarter revenue grew 87.8% year over year (PRIMARY, EDGAR), far above the group pace, and revenue is not shrinking, so the value-trap check does not apply. Delivered demand check: the Packaged foods, meats & agriculture group's median growth was 5.8% year over year — demand steady, and this company grew far faster than that pace.

9.7×
Forward P/E — price vs next year’s expected earnings (secondary source)
13.6×
Peer median forward P/E — closest comparable companies
19.7×
Trailing P/E — price vs the last twelve months of earnings
0.2×
Price / sales

What would change this label: Move to FAIRLY PRICED if the forward P/E rises to about 12.21x or above (0.90x the peer median) at unchanged estimates, or if revenue growth falls back to the group median of about 5.8% or below for two quarters while the multiple stays above 12x. The discount would widen further if growth stays far above the group pace while the forward multiple stays below 10x.

In simple words

Bunge trades and processes oilseeds and grains that go into food, animal feed and fuel. Its shares trade at under 10 times expected earnings, well below similar companies at about 14 times, even though its sales grew very fast in the latest quarter. On those numbers the shares look undervalued — cheap next to peers, with no sign in the brief that sales are shrinking.

Words we use, in plain English: P/E ratio — the share price divided by earnings per share; how many dollars you pay for one dollar of yearly profit. Forward P/E — the same, using next year’s expected earnings. Free cash flow — cash a company has left after running the business and buying equipment. TTM — the last twelve months. Drawdown — the worst fall from a peak to the low after it.
The share price vs the market — six years
Bunge Global (BG)S&P 500 (SPY)
771331902473042021202220232024202520262020-09-012026-10-27

Both lines start at 100 on 2020-09-01. Over the full window Bunge Global returned +122.92% and the S&P 500 +118.28% (price returns; dividends not reinvested). Worst peak-to-trough fall for Bunge Global: -45.5% (2022-04-18 to 2025-02-12). Source: Nasdaq official daily history.

What the label rests on

Forward P/E is 9.67x against a peer median of 13.57x, a ratio of 0.71x — well below the 0.90 fair-range floor — with trailing P/E 19.72x and PEG not reported (shown as n/a on the statistics page). Latest-quarter revenue grew 87.8% year over year (PRIMARY, EDGAR), far above the group pace, and revenue is not shrinking, so the value-trap check does not apply. Delivered demand check: the Packaged foods, meats & agriculture group's median growth was 5.8% year over year — demand steady, and this company grew far faster than that pace. The company’s forward P/E is 9.7× against a peer median of 13.6×. Its own history: UNVERIFIED — no sourced range available. Sector demand read: Delivered demand check: the Packaged foods, meats & agriculture group's median latest-quarter revenue growth was 5.8% year over year (SEC filings) — demand steady. This company grew 87.8%, far ahead of that pace. Latest-quarter sales growth was +87.8% versus a year earlier (SEC filings).

CompanyPrice (Oct 28, 2026)Forward P/ETrailing P/E
Bunge Global (BG)$101.109.7×19.7×
TSN$55.6216.0×34.4×
GIS$33.1610.7×—
SJM$125.2412.4×58.3×
MKC$45.9814.9×8.3×
HRL$20.6813.6×33.3×
Peer median13.6×

Multiples: stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026. Peer set chosen by sector; the median is the middle value of the set. The label and its numbers were recorded in the programme’s label registry on Oct 28, 2026 and will be scored at 6 and 12 months.

Sales, profit and cash

Sales each quarter, and the gross margin
SalesGross margin (right axis)
$0B$9B$18B$27B0%5%11%Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Gross margin = gross profit divided by sales, from SEC filings.

Cash left over each quarter (free cash flow)
PositiveNegative
$-2B$0B$2BMar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Free cash flow = cash from operations minus spending on plant and equipment, both from the company’s SEC cash-flow statement. Gaps are quarters where that spending line is not separately tagged in the filings — shown as gaps, never estimated.

QuarterSalesGross marginNet incomeEPS (GAAP, diluted)Free cash flow
Q/E Mar 2026
2026-03-31
$21.9B3.5%$68M0.35$-877M
Q/E Dec 2025
2025-12-31
$23.8B4.2%$95M0.49$809M
Q/E Sep 2025
2025-09-30
$22.2B4.8%$166M0.84$385M
Q/E Jun 2025
2025-06-30
$12.8B5.8%$354M2.61$-1.5B
Q/E Mar 2025
2025-03-31
$11.6B5.1%$201M1.48$-595M
Q/E Dec 2024
2024-12-31
$13.5B8.0%$602M4.36$564M
Q/E Sep 2024
2024-09-30
$12.9B6.0%$221M1.56$973M
Q/E Jun 2024
2024-06-30
$13.2B5.0%$70M0.48$-1.8B
Q/E Mar 2024
2024-03-31
$13.4B6.5%$244M1.68$758M
Q/E Dec 2023
2023-12-31
$14.9B8.4%$616M4.18$1.1B
Q/E Sep 2023
2023-09-30
$14.2B7.3%$373M2.47$1.1B
Q/E Jun 2023
2023-06-30
$15.0B9.1%$622M4.09$-827M

The last twelve reported quarters. Full 17-quarter history sits in the data pack behind this page. A dash means the figure is not tagged as a standalone quarter in the company’s SEC facts (the usual case is the fourth quarter, which many companies only report inside the full-year filing) — it is missing, not zero.

Earnings: getting better or worse?

Each box is one quarter’s earnings per share (EPS). Green means EPS was higher than the same quarter a year earlier; red means lower; a dash means the figure is not tagged in the filings.

Jun 2022
1.34
Sep 2022
2.49
Dec 2022
2.21
Mar 2023
4.15
Jun 2023
4.09
Sep 2023
2.47
Dec 2023
4.18
Mar 2024
1.68
Jun 2024
0.48
Sep 2024
1.56
Dec 2024
4.36
Mar 2025
1.48
Jun 2025
2.61
Sep 2025
0.84
Dec 2025
0.49
Mar 2026
0.35

Basis: GAAP diluted EPS from SEC company facts, compared with the same quarter a year earlier.

Key facts

ItemValue
Company (legal name in filings)Bunge Global SA
Chief executiveGreg Heckman (source: https://en.wikipedia.org/wiki/Bunge_Limited)
SectorConsumer Staples — Agricultural Products & Services — trades and processes oilseeds and grains into ingredients for food, animal feed and fuel
Share price (Oct 28, 2026)$101.10
Market value (market cap)$19.7B — share price times shares outstanding of 194,018,115 (SEC filings; SEC EDGAR dei EntityCommonStockSharesOutstanding (latest))
Sales, last twelve months$80.5B
Net income, last twelve months$683M
Free cash flow, last twelve months$-1.2B
Latest reported quarterQ/E Mar 2026 (of 17 quarters in the data pack)
Six-year price return vs S&P 500+122.92% vs +118.28%
Worst peak-to-trough fall-45.5% (2022-04-18 to 2025-02-12)

What we could not verify

  • Free cash flow is absent for one or more quarters: either the filer does not separately tag PP&E purchases in its EDGAR cash-flow facts (common for banks), or — for a successor registrant's newest quarter — the cash-flow lines are year-to-date without the prior-quarter rung needed to difference them. Affected quarters are null in the data, never estimated.
  • Own-history P/E range not yet compiled for this company in the Phase 1 batch run; the label rests on peer-median, growth and PEG evidence.
  • PEG ratio was shown as n/a on the statistics page, so no PEG evidence is available for this label.
  • The secondary source's implied revenue (market cap divided by P/S, about $92.48B) differs by more than 35% from one revenue figure in the brief's key facts; the label uses the EDGAR revenue growth figure of 87.8%.
  • Guidance record (each quarter scored against the guidance the company gave the quarter before) is not yet compiled for this company — it is a Phase 2 layer. The earnings strip below therefore uses reported EPS versus a year earlier, which is fully sourced from filings.

The IT factor — the most exciting thing the market is overlooking — is not assessed on an X-Ray page. It belongs to the Deep Dive (Phase 2), where it gets the evidence standard it needs. Leadership-era scoring (the six years split by chief executive) is likewise a Phase 2 layer; this page names the current chief executive only, from a sourced profile.

Sources

  • SEC EDGAR submissions — Filing index; company legal name. https://data.sec.gov/submissions/CIK0001996862.json
  • SEC EDGAR company facts — Quarterly financial spine: revenue, gross profit, net income, GAAP diluted EPS, operating cash flow, PP&E capex, buybacks, dividends, diluted shares. https://data.sec.gov/api/xbrl/companyfacts/CIK0001996862.json
  • Nasdaq official daily history — Daily closes for the company; SPY (assetclass=etf) saved as raw/nasdaq_spy_raw.json over identical dates. https://api.nasdaq.com/api/quote/BG/historical?assetclass=stocks
  • Valuation multiples and peer figures — stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026; see valuation_label.md in the data pack.

Conventions: earliest-filed value per period, as first reported; cash-flow years-to-date differenced quarter by quarter; EPS never differenced; free cash flow = operating cash flow minus plant-and-equipment spending. This page is a dated snapshot — updates are new versions, never silent edits.

← All X-RaysS&P 500 Full Coverage — Phase 1 · Oct 28, 2026